Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2000-05-11
2004-10-05
Fredman, Jeffrey (Department: 1637)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S001210, C424S450000, C424S213100, C424S402000, C424S490000, C514S054000, C514S059000, C536S112000
Reexamination Certificate
active
06800298
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to compositions, methods and apparatus for lubrication of mammalian joints, both natural and artificial.
BACKGROUND OF THE INVENTION
Synovial fluid acts to lubricate the bearing surfaces of bones and bone-like structures which are held in frictional contact within joints. Synovial fluid lubricates tendons, cartilage, bones, ligaments, and other biological structures that move within the body relative to each other. The human knee is an example of a joint that uses synovial fluid advantageously to provide for lubrication and for friction reduction. Synovial fluid is naturally excreted into the cavity of the joint in a normal healthy knee.
There are publications disclosing the use of propylene glycol and phospholipids in synovial fluid. For example, PCT publication WO 97/22345 to Hills et al. provides a discussion of a method of lubrication of synovial fluid by administering a composition comprising a mixture of phospholipids and propylene glycol. Another publication, PCT publication 89/01777 discloses using hyaluronic acid in saline solution as a lubricant for joints. Hyaluronic acid compositions may reduce the coefficient of kinetic friction between surfaces in contact with each other, and in particular, load bearing surfaces. Another publication, EP 0 767 212A1, is directed to a process for producing an aqueous solution of phosphorycholine group bearing polymer. This publication is directed to producing such compositions as starting materials for cosmetics having skin beautifying effects, and as contact lens cleaning agents.
U.S. Pat. No. 5,902,800 to Green et al. describes pharmaceutical compositions containing dextran, and a method for treatment of joint inflammation and pain brought about by arthritis, physical trauma, or infection using such dextran-containing formulations. The method comprises administering a bimodal molecular weight dextran formulation in conjunction with drugs or pharmaceuticals, such as corticocosteroids, anti-inflammatory drugs, and antibiotics to enhance the effect of dextran in relieving pain and inflammation in an inflamed joint.
SUMMARY OF THE INVENTION
The present invention may be presented in many different embodiments, and representative embodiments are described herein. The invention is not limited to only those embodiments described, and a person of skill in the art may readily apply the invention in other ways that are apparent from this specification. Numerous examples are provided, but the invention is not intended to be limited to only those examples provided.
The invention generally comprises a biologically compatible lubricant composition useful for; injecting into damaged or diseased joints, filling cavities and spaces in artificial joints, applying to joints in connection with post-surgical procedures, and other applications in which a synovial fluid having good lubricity and biocompatibility is desirable. Treatment of osteo-arthritic joints is one application for compositions of this invention. In other applications, a composition may be injected following a joint injury, as a visco-supplementation. The compositions may be used as lubricants in artificial joints following total joint replacements. Further, the compositions may be used for maintenance of an artificial joint to minimize wear of bearing surfaces in humans or mammals. In some applications, the compositions may be used to investigate or measure the wear performance of artificial joints in vitro in a joint stimulator for research purposes.
The composition generally comprises an effective amount of dextran and a lipid. In one aspect of the invention, the lipid may be selected from the group of lipids comprising: lipopolysaccharides, sphingolipids, glycolipids, phosphatidyl cholines, phosphatidyl ethanolamines, sphingomyelins, phosphatidyl inositols, phosphatidyl serines, phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, phosphatidylinositol, sphingomyelin, dipalmitoyl phosphatidylcholine (DPPC), and phosphatidyl cholines.
In one embodiment of the invention, the composition is presented which has a rheology of the fluid between about 1 and 20 Pa (sec) at a temperature range of about 25-45 C. The dextran typically comprises less than 40% by weight of the solution, and more preferably about 20% by weight, and still more preferably about 10% by weight or less.
In another aspect of the invention, a synthetic synovial fluid is disclosed comprising dextran and a phospholipid. In many instances the fluid comprises a crosslinked hydrogel. Many different phospholipids work well in this composition, and one desirable phospholipid is dipalmitoyl phosphatidylcholine (DPPC), which is further discussed in connection with the Example below.
A method of lubricating a joint or other physiological articulation is also presented by way of this invention. The method generally comprises administering to a joint or articulation in an effective amount of a composition comprising one or more phospholipids and dextran-based hydrogel which acts as a carrier. The method may be applied in instances for which the joint is a natural joint, or an artificial joint. In one application, the method may be applied in which the administration of the composition follows a total joint replacement operation. In one aspect of the invention, the method may include applying the lubricant compositions into an artificial joint simulator to simulate wear performance of the joint.
REFERENCES:
patent: 5238929 (1993-08-01), Koupchinov et al.
patent: 5614515 (1997-03-01), Rodgers et al.
patent: 5625036 (1997-04-01), Hawkins et al.
patent: 5866570 (1999-02-01), Liang et al.
patent: 5874500 (1999-02-01), Rhee et al.
patent: 5902800 (1999-05-01), Green et al.
patent: 5906934 (1999-05-01), Grande et al.
patent: 5912270 (1999-06-01), Dixon et al.
patent: 5939323 (1999-08-01), Valentini et al.
patent: 5980887 (1999-11-01), Isner et al.
patent: 5985330 (1999-11-01), Collin
patent: 6475516 (2002-11-01), DiCosmo et al.
patent: 8901777 (1989-03-01), None
patent: 9722345 (1997-06-01), None
patent: 0499164 (1992-08-01), None
patent: 0499164 (1992-08-01), None
patent: 0810239 (1997-03-01), None
patent: 0810239 (1997-12-01), None
patent: 0767212 (1997-04-01), None
patent: 9534287 (1995-12-01), None
patent: WO 9615795 (1996-05-01), None
patent: 97/22345 (1997-06-01), None
patent: WO 98/00170 (1998-01-01), None
Nangia et al, “Analysis of preparation of dextran hydrogel membranes as a wound dressing”, Drug Development and Industrial Pharmacy, (1991) 17(12): 1609-1624.*
Journal of Biomedical Materials Research, vol. 15, 591-603, (1981), Biodegradation of a poly-(&agr;-amino acid) hydrogel.
Butterworth Heinemann Biomaterials 16 (1995) 441-447, Degradation of polydispersed poly(L-lactic acid) to modulate lactic acid release, Great Britain.
Elsevier Biomaterials 18 (1997), In vitro degradation of pH-sensitive hydrogels containing aromatic azo bonds, Great Britain.
Butterworth-Heinemann Biomaterials 1994, vol. 14 No. 11, 920-925, Molecular Weight dependence of calcification of polyethylene glycol hydrogels,.
ASAIO Journal 1993 M326-M331, Newly Designed Tissue Adhesion Prevention Technology Based on Photocurable Mucopolysaccharides, Japan.
American Chemical Society, Bioconjugate Chem. 1997, 8, 686-694, Synthesis and in Vitro Degradation of New Polyvalent Hydrazide Cross-linked Hydrogels of Hyaluronic Acid.
Department of Orthopaedic Surgery, University Hospital of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark, Pathological Human Synovial FluidsDepartment of Pharmaceuties, Macromolecules 1995, 28, 6317-6322, Synthesis, Characterization, and Polymerization of Glycidyl Methacrylate Derivatized Dextran.
Polytechnic Institute of Jassy, Jassy, Romania, Polymeric Biomaterials, 1993.
Phospholipase A2in Human Cartlage, vol. 48 25, 1991, Table 2, Enzymatic Hydrolysis of 1-Palmitoyl-2-(14C)-Palmitoyl-3-Phosphatidylcholine.
Journal of Biomedical Materials Research, vol. 29, 421-429 (1995), Wettability and interfacial interactions in bioceramic-body-liquid systems.
The Journal of Rheumat
Burdick Julie-Anne Mason
Laberge Martine
Lickfield Gary
Clemson University
Dority & Manning P.A.
LandOfFree
Biological lubricant composition and method of applying... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biological lubricant composition and method of applying..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biological lubricant composition and method of applying... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3278493